Which of the following is a key function of Desmopressin in treating bleeding disorders?

• A. Induces vasodilation
• B. Increases fibrinogen levels
• C. Stimulates exocytosis of VWF from endothelial cells
• D. Directly activates platelets

Answer: (C)

Desmopressin plays a significant role in treating bleeding disorders primarily through its ability to stimulate the exocytosis of von Willebrand factor (VWF) from endothelial cells. VWF is crucial for normal hemostasis, as it facilitates platelet adhesion to sites of vascular injury and stabilizes factor VIII in the circulation. By promoting the release of VWF, Desmopressin enhances platelet function and improves clot formation in individuals with conditions such as von Willebrand disease and mild hemophilia A.

This function is particularly important in scenarios where there is a deficiency or dysfunction of VWF, as it can help mitigate bleeding episodes. The increase in VWF levels assists in correcting the underlying coagulopathy associated with these bleeding disorders, making Desmopressin an effective treatment option.

The other choices reflect different mechanisms of action that do not pertain to the primary function of Desmopressin. For instance, inducing vasodilation or directly activating platelets may be related to other therapeutic agents or factors involved in hemostasis, but they are not the main actions attributed to Desmopressin in this context.